Sandro V. Porceddu
Expertise in
2
conditions

Sandro V. Porceddu

199 Ipswich Road, 
Woolloongabba, QLD, AU 
Expertise in
2
conditions
199 Ipswich Road, 
Woolloongabba, QLD, AU 

Overview

Sandro Porceddu practices practicing medicine in Woolloongabba, Australia.

Mr. Porceddu is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Human Papillomavirus Infection, Swallowing Difficulty, Squamous Cell Skin Carcinoma, and Laryngectomy.

He is actively involved in clinical research, co-authoring 147 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

199 Ipswich Road, Woolloongabba, QLD, Australia
Other Locations
Ipswich Road, Woolloongabba, QLD, Australia
Princess Alexandra Hospital Ipswich Road, Woolloongabba, QLD, Australia
199 Ipswich Road, Ipswich, QLD 4102, Australia
St. Andrews Place, East Melbourne, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

TROG12.01 A Randomised Trial of Weekly Cetuximab and Radiation Versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma
TROG12.01 A Randomised Trial of Weekly Cetuximab and Radiation Versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Drug, Radiation
Study Drugs: Cetuximab, Cisplatin
Study Phase: Phase 3

145 Total Publications

Sensorineural hearing outcomes in HPV-positive oropharyngeal cancer: a secondary analysis of the TROG 12.01 randomized trial (SHOUT).
Sensorineural hearing outcomes in HPV-positive oropharyngeal cancer: a secondary analysis of the TROG 12.01 randomized trial (SHOUT).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 23, 2026

Frequently Asked Questions about Sandro V. Porceddu

Is Sandro V. Porceddu a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Sandro V. Porceddu is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sandro V. Porceddu participate in research or clinical trials?

Yes. Sandro V. Porceddu has published 145 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Sandro V. Porceddu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Porceddu's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile